UBS Group’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

UBS Group’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,730	Closed	-$37.6K	–	11393
2022 Q4	$37.6K	Buy	3,730 +1,545	+71%	+$15.4K	﹤0.01%	7025
2022 Q3	$21K	Buy	2,185 +2,128	+3,733%	+$21K	﹤0.01%	7368
2022 Q2	$1K	Sell	57 -309	-84%	-$3.03K	﹤0.01%	10138
2022 Q1	$4K	Sell	366 -2,224	-86%	-$21.6K	﹤0.01%	9383
2021 Q4	$25K	Buy	+2,590	New	+$25.2K	﹤0.01%	7606

UBS Group's MSAC Position: Q1 2023 in Review

UBS Group sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 3,730 shares — an estimated $37.6K sold.

UBS Group first reported a position in MSAC in Q4 2021 and held it in 5 quarters. The position peaked at $37.6K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

UBS Group reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
UBS Group sold 3,730 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $37.6K.
UBS Group first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
UBS Group's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $37.6K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.